Bal Pharma Ltd to consider merger

A meeting of Board of Directors of Bal Pharma Ltd is scheduled to be held on 9.03.2022 i.e on Wednesday to consider approval of scheme of amalgamation between the company and its wholly owned subsidiary i.e Golden Drugs Private Ltd, subject to the approval of applicable statutes and shareholders of the Company.

Shares of Bal Pharma Limited was last trading in BSE at Rs. 113.20 as compared to the previous close of Rs. 108.30. The total number of shares traded during the day was 11332 in over 548 trades.

The stock hit an intraday high of Rs. 117.40 and intraday low of 105.70. The net turnover during the day was Rs. 1285829.00.

Source : Equity Bulls

Keywords

BalPharma INE083D01012 Merger Subsidiary GoldenDrugs